We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+17.18%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$2.45B
AUM Growth
–
Cap. Flow
+$2.27B
Cap. Flow
% of AUM
92.72%
Top 10 Holdings %
Top 10 Hldgs %
26.73%
Holding
105
New
105
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$76M |
| 2 |
Texas Instruments
TXN
|
+$66.9M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$65M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$62.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$59.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.09% |
| 2 | Healthcare | 40.97% |
| 3 | Communication Services | 13.83% |
| 4 | Financials | 1.4% |
| 5 | Industrials | 1.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Qualcomm
QCOM
$164B
| $16.8M | 0.69% |
+190,185
| New | +$15.9M |
|
52
Booking.com
BKNG
$156B
| $16.7M | 0.68% |
+203,100
| New | +$15.9M |
|
|
HOLX
53
DELISTED
Hologic
HOLX
| $15.7M | 0.64% |
+300,904
| New | +$15M |
|
54
PTC Therapeutics
PTCT
$6.18B
| $15.2M | 0.62% |
+317,226
| New | +$13.5M |
|
55
Envista
NVST
$4.62B
| $14.9M | 0.61% |
+504,219
| New | +$14.3M |
|
56
Nokia
NOK
$46.9B
| $13.7M | 0.56% |
+3,701,074
| New | +$14.6M |
|
|
GLUU
57
DELISTED
Glu Mobile Inc.
GLUU
| $13.5M | 0.55% |
+2,237,693
| New | +$12.8M |
|
58
Lattice Semiconductor
LSCC
$16B
| $13.5M | 0.55% |
+706,369
| New | +$13.6M |
|
59
Walt Disney
DIS
$171B
| $13.3M | 0.55% |
+92,261
| New | +$12.9M |
|
60
BioMarin Pharmaceuticals
BMRN
$11.9B
| $13.3M | 0.54% |
+157,707
| New | +$11.9M |
|
|
TPTX
61
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $12.4M | 0.51% |
+199,378
| New | +$9.49M |
|
62
Zymeworks
ZYME
$1.62B
| $12.4M | 0.51% |
+273,118
| New | +$9.92M |
|
|
ALXN
63
DELISTED
Alexion Pharmaceuticals
ALXN
| $12.3M | 0.5% |
+114,170
| New | +$12.2M |
|
|
GWPH
64
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $12.3M | 0.5% |
+117,366
| New | +$13.2M |
|
|
IMMU
65
DELISTED
Immunomedics Inc
IMMU
| $12.2M | 0.5% |
+574,957
| New | +$10.1M |
|
66
CVS Health
CVS
$135B
| $11.8M | 0.48% |
+158,697
| New | +$11.1M |
|
67
ICU Medical
ICUI
$4.16B
| $11.7M | 0.48% |
+62,571
| New | +$10.8M |
|
68
DexCom
DXCM
$29B
| $11.3M | 0.46% |
+205,844
| New | +$9.76M |
|
69
Avantor
AVTR
$9.73B
| $11.2M | 0.46% |
+615,127
| New | +$9.79M |
|
70
Teleflex
TFX
$5.96B
| $10.7M | 0.44% |
+28,340
| New | +$9.76M |
|
|
ZGNX
71
DELISTED
Zogenix, Inc.
ZGNX
| $9.59M | 0.39% |
+183,987
| New | +$8.42M |
|
|
MNTA
72
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $9.46M | 0.39% |
+479,499
| New | +$7.67M |
|
73
BioCryst Pharmaceuticals
BCRX
$2.42B
| $8.34M | 0.34% |
+2,417,829
| New | +$6.08M |
|
|
DRNA
74
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $8.19M | 0.33% |
+371,868
| New | +$7.48M |
|
|
NVRO
75
DELISTED
NEVRO CORP.
NVRO
| $8.14M | 0.33% |
+69,233
| New | +$6.86M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Woodline Partners, which disclosed 105 positions worth $2.45B. Its ten largest holdings account for 27% of the portfolio.
Its largest position is Seagen Inc. Common Stock: 716,700 shares worth $81.9M.
By sector, the portfolio is most concentrated in Technology at 41% of assets, followed by Healthcare and Communication Services.
- Woodline Partners's largest Q4 2019 buy was Seagen Inc. Common Stock: 716,700 shares worth $81.9M.
- Woodline Partners's ten largest holdings make up 27% of its $2.45B portfolio in Q4 2019.
- Woodline Partners disclosed 105 positions in Q4 2019, its first 13F filing on record.
Based on Woodline Partners's 13F filing for Q4 2019, filed 14 Feb 2020.